Crossref
Research on the Cost Control Problem of Biological Companies—Taking Tianjin Meili as an Example
Accounting, Auditing and Finance · 2023
DOI: 10.23977/accaf.2023.040107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Accounting, Auditing and Finance, 2023.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2023). Research on the Cost Control Problem of Biological Companies—Taking Tianjin Meili as an Example. Accounting, Auditing and Finance. https://doi.org/10.23977/accaf.2023.040107
Vancouver
Research on the Cost Control Problem of Biological Companies—Taking Tianjin Meili as an Example. Accounting, Auditing and Finance. 2023. doi:10.23977/accaf.2023.040107
BibTeX
@article{euvimed2023,
title = {Research on the Cost Control Problem of Biological Companies—Taking Tianjin Meili as an Example},
journal = {Accounting, Auditing and Finance},
year = {2023},
doi = {10.23977/accaf.2023.040107}
}
EUVIMED